<page><title>PPM-X syndrome</title><url>https://medlineplus.gov/genetics/condition/ppm-x-syndrome</url><content>PPM-X syndrome
To use the sharing features on this page, please enable JavaScript.
Description
PPM-X syndrome is a condition characterized by psychotic disorders (most commonly
bipolar disorder
), a pattern of movement abnormalities known as parkinsonism, and mild to severe intellectual disability with impaired language development. Other symptoms may include muscle stiffness (spasticity), exaggerated reflexes, and an abnormally small head (
microcephaly
). Affected males may have enlarged testes (macro-orchidism). Not all affected individuals have all these symptoms, but most have intellectual disability. Males with this condition are typically more severely affected than females, who usually have only mild intellectual disability or learning disabilities.
Frequency
PPM-X syndrome is thought to be a very rare condition, although its prevalence is unknown.
Causes
Mutations in the
MECP2
gene cause PPM-X syndrome. The
MECP2
gene provides instructions for making a protein called MeCP2 that is critical for normal brain function. Researchers believe that this protein has several functions, including regulating other genes in the brain by switching them off when they are not needed. The MeCP2 protein likely plays a role in maintaining connections (
synapses
) between
nerve cells
. The MeCP2 protein may also control the production of different versions of certain proteins in nerve cells. Although mutations in the
MECP2
gene disrupt the normal function of nerve cells, it is unclear how these mutations lead to the signs and symptoms of PPM-X syndrome.
Some
MECP2
gene mutations that cause PPM-X syndrome disrupt attachment (binding) of the MeCP2 protein to DNA, and other mutations alter the 3-dimensional shape of the protein. These mutations lead to the production of an MeCP2 protein that cannot properly interact with DNA or other proteins and so cannot control the expression of genes. It is unclear how
MECP2
gene mutations lead to the signs and symptoms of PPM-X syndrome, but misregulation of genes in the brain likely plays a role.
Learn more about the gene associated with PPM-X syndrome
MECP2
Inheritance
More than 99 percent of PPM-X syndrome cases occur in people with no history of the disorder in their family. Many of these cases result from new mutations in the
MECP2
gene.
A few families with more than one affected family member have been described. These cases helped researchers determine that PPM-X syndrome has an X-linked pattern of inheritance. A condition is considered X-linked if the mutated gene that causes the disorder is located on the X chromosome, one of the two
sex chromosomes
in each cell. In males, who have only one X chromosome, a mutation in the only copy of the gene in each cell is sufficient to cause the condition. In females, who have two copies of the X chromosome, one altered copy of the gene in each cell can lead to less severe features of the condition or may cause no signs or symptoms at all. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
Other Names for This Condition
MRXS13
PPMX
X-linked mental retardation, syndromic 13
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Rett syndrome
Genetic and Rare Diseases Information Center
X-linked intellectual disability-psychosis-macroorchidism syndrome
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Catalog of Genes and Diseases from OMIM
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13; MRXS13
Scientific Articles on PubMed
PubMed
References
Francke U. Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat Clin
Pract Neurol. 2006 Apr;2(4):212-21. doi: 10.1038/ncpneuro0148.
Citation on PubMed
Gonzales ML, LaSalle JM. The role of MeCP2 in brain development and
neurodevelopmental disorders. Curr Psychiatry Rep. 2010 Apr;12(2):127-34. doi:
10.1007/s11920-010-0097-7.
Citation on PubMed
or
Free article on PubMed Central
Lambert S, Maystadt I, Boulanger S, Vrielynck P, Destree A, Lederer D,
Moortgat S. Expanding phenotype of p.Ala140Val mutation in MECP2 in a 4
generation family with X-linked intellectual disability and spasticity. Eur J Med
Genet. 2016 Oct;59(10):522-5. doi: 10.1016/j.ejmg.2016.07.003. Epub 2016 Jul 25.
Citation on PubMed
Psoni S, Sofocleous C, Traeger-Synodinos J, Kitsiou-Tzeli S, Kanavakis E,
Fryssira-Kanioura H. Phenotypic and genotypic variability in four males with
MECP2 gene sequence aberrations including a novel deletion. Pediatr Res. 2010
May;67(5):551-6. doi: 10.1203/PDR.0b013e3181d4ecf7.
Citation on PubMed
Villard L. MECP2 mutations in males. J Med Genet. 2007 Jul;44(7):417-23. doi:
10.1136/jmg.2007.049452. Epub 2007 Mar 9.
Citation on PubMed
or
Free article on PubMed Central
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>